Our Story

In 2014, Pansend LLC, the life sciences segment of INNOVATE (NYSE: VATE), founded R2 together with Blossom Innovations, LLC and Massachusetts General Hospital to develop a technology based on their patented method of CryomodulationTM. Since that time, R2 has conducted the design, development and extensive clinical research to bring Glacial Rx and Glacial Spa to market along with an exciting product pipeline.

down-arrow

Timeline

2014

The Founding of R2

David A. Present, M.D. and Cherine Eldumiati Plumaker, General Partners of Pansend Life Sciences, co-founded R2 Technologies and licensed exclusive intellectual property from Massachusetts General Hospital and Blossom Innovations on their patented method of CryomodulationTM.

Research

R2 begins the research and development of the technology around CryomodulationTM.

2015
2016

FDA Clearance

R2 receives clearance for the removal of benign lesions of the skin.

FDA Clearance

R2 receives clearance for their next-generation system.

2017
2018

First Published Manuscript from founders

Lasers in Surgery and Medicine introduces the treatment of benign lesions utilizing a novel dermal cooling system.

Strategic Partnership

R2 closes strategic investment and commercial partnership with Huadong Medicine Co., Ltd.

2019
2020

FDA Clearance

R2 receives expanded indication for the temporary reduction of pain, swelling and inflammation.

Glacial Rx and Glacial Spa
treatments available

First commercial installations and treatments underway in select countries.

FDA Clearance

R2 receives expanded indication when dermabrasion tips are used, the intended use includes general dermabrasion, scar revision, acne scar revision, and tattoo removal.

2021

Scientific Founders

R. ROX ANDERSON, M.D.

R. ROX ANDERSON, M.D.

DIETER MANSTEIN, M.D., PhD

DIETER MANSTEIN, M.D., PhD

HENRY H. L. CHAN, M.D., PhD

HENRY H. L. CHAN, M.D., PhD

R2 Team

Tim has 17 years of commercial experience in the aesthetic medical device industry which includes key leadership roles at Reliant Technologies and ZELTIQ. He was at the forefront of the successful product launches of Fraxel and CoolSculpting as well as the growth and scaling of those two ventures from start-up to IPO/acquisition. R2 will be Tim’s third successive company delivering a game-changing product to market that originated in the labs of world-renowned serial inventors, Drs. Rox Anderson, Dieter Manstein and Henry Chan.

Tim is a native of Ohio. He received his BBA in Marketing from Ohio University in 1997 and his MBA from Campbell University in 1999. He has been involved in various youth mentorship and philanthropic organizations. He is a member of the Ohio University Executive Advisory Board, he’s a sponsor of the Ohio University Select Leaders Program and he’s an Ambassador for the Gratitude Network.

TIM HOLT

TIM HOLT

President & CEO

Kristine has dedicated her 25-year career to cryobiology research and the development of cold-based medical devices. She held a leadership position at ZELTIQ and dedicated the last decade to aesthetic applications for cold therapies.

KRISTINE TATSUTANI

KRISTINE TATSUTANI

Chief Science & Technology Officer

Han is a globally versed executive with 25+ years of financial and operations leadership, 11 of them in FDA-regulated industries. His experience spans a spectrum of industries from consumer-packaged goods and consumer appliances to pharmaceuticals and medical devices. He has held five global CFO roles across large, midsize, and small companies and specializes in acquisition and integration.

HAN JANSEN

HAN JANSEN

Chief Financial Officer

Pete comes to R2 with over 20 years of sales leadership experience in aesthetic device, dental, and software technology. He led the Southeast US teams at Thermage and Solta Medical to award winning performances with brands such as Thermage, Fraxel, Isolaz, and Clear + Brilliant.

As the General Manager for distributors Patterson Dental and Benco Dental, he led business units up to $50M in annual sales revenues.

Most recently, Pete led the US sales efforts at startup fintech provider HintMD, growing the business from zero to over $250M in annual processing sales. HintMD was successfully acquired by Revance Aesthetics in July 2020.

PETE COUSINS

PETE COUSINS

Sr. Vice President of Global Sales

Ben has over 22 years of commercial experience, thirteen of which are directly in medical aesthetics. He is passionate about people and has a strong history leading both sales and marketing teams.

BEN NEWCOTT

BEN NEWCOTT

Vice President of Marketing

Casey has 20+ years’ experience leading high performing teams in sales operations, customer service, and logistics in the medical aesthetics and life science industries. Most recently with ZELTIQ where he helped to launch the CoolSculpting brand and commercial programs.

CASEY TORREZ

CASEY TORREZ

Vice President of Operations

Board of Directors

David A. Present, MD, Chairman, Founder, and General Partner, Pansend Life Sciences, LLC

Cherine Eldumiati Plumaker, Vice Chairman, Founder, and General Partner, Pansend Life Sciences, LLC

Irina Erenburg, PhD, Founder and Chief Executive Officer, Blossom Innovations, LLC

Yuhang Zhao, PhD, MBA, Adviser to China Grand, Inc.

Seth Orlow, MD, PhD, Professor and Chair of Dermatology, NYU School of Medicine

Tim Holt, MBA, President and Chief Executive Officer, R2 Technologies, Inc.

Dovid Tu, APAC General Manager

Exclusive Partners

Allies of Skin

Founded in 2016 by Nicolas Travis, a Forbes “30 Under 30,” and sold in more than 29 markets worldwide and counting, cult-favorite brand Allies of Skin creates multi-benefit formulas for all skin types that work harder and smarter. Each multitasking product takes clinically proven actives and combines them with innovative, optimally concentrated, biocompatible ingredients that work synergistically to provide maximum results. Allies of Skin’s clinical-grade formulas are clean and effective, smart and sophisticated, and packed with the greatest amount of active ingredients possible, winning numerous prestigious beauty awards from magazines including Allure, Harper’s Bazaar, Teen Vogue and InStyle.

Huadong Medicine Company, Limited

Huadong Medicine Co., Ltd., is a leading Chinese pharmaceutical company based in Hangzhou, China. Founded in 1993, Huadong Medicine has fully integrated R&D, manufacturing, distribution, sales and marketing capabilities. Huadong Medicine’s product portfolio and pipeline are specialized in oncology, immunology, nephrology and diabetes. The company’s annual revenue in 2019 exceeded 5 billion USD. Huadong Medicine has 12,000 employees, among which 1,000 are dedicated to R&D. Huadong Medicine possesses one of the most extensive commercial coverage and marketing capabilities in China. Huadong Medicine Company – Patient Centered, Science Driven.

Recent News

Content Hub

At R2 Technologies, we believe in empowering our providers with the most up to date information. Find links to latest news, upcoming events, and so many more resources like product guides and on-demand webinars!

Content Hub

Contact us

2603 Camino Ramon, Suite 200, Bishop Ranch 3,
San Ramon, CA 94583
Email ‒ info@r2technologies.com
Call ‒ (925) 378-4400

801 Brickell Ave., Suite # 711
Miami FL, 33131